Low Dose Lipopolysaccharide-Induced Depressive-Like Phenotype is Mediated by Proinflammatory Cytokines in Mice and Role of Ketamine
Shuvranshu Praharaj, V. K. Kalaichelvan, Vedigounder Murugan, V. Venkatachalam, Ishtiyaque Ahmad
Indian Journal of Pharmaceutical Education and Research August 10, 2024 DOI: 10.5530/ijper.58.3s.79 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal experiment Peer reviewed |
|---|---|
| Population | C57BL/6J mice |
| Interventions | Ketamine Lipopolysaccharide (LPS) |
| Dose | 10 and 30 mg/kg (mpk) ketamine; low-dose LPS (amount not specified) |
| Duration | 6 days of LPS injection |
| Measures | forced swim test, sucrose preference test, western blot (Jess system), ELISA, LC-MS/MS |
| Topics | Esketamine Ketamine |
| Key findings | Ketamine prevented LPS-induced depressive-like behavior in mice, decreasing immobility in the forced swim test and increasing sucrose preference. It also reduced plasma and brain levels of IFN-γ, IL-6, TNF-α, and IL-1β, with brain-to-plasma ketamine ratios of 0.70 (10 mg/kg) and 0.82 (30 mg/kg). The authors suggest these effects may explain ketamine's anti-depressant properties. |
Abstract
Background: Depression is a common mental illness, with an estimated 3.8% of global population affected. In the pathophysiology of depression, ketamine acts quickly in patients. Treatment with low-dose ketamine upon administration to stressed C57BL/6J mice is now a major translational research area to facilitate further innovation.
Objectives: The present work was aimed to establish a depressant like animal model after 6 days of LPS injection, where LPS did not promote body weight loss.
Materials and Methods: Peripheral administration of low dose of Lipopolysaccharide (LPS) activates cytokines and culminate in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in the forced swim and anhedonia in sucrose preference tests. Cytokines like TNF-α, IL-6, IL-1β and IFN-γ were determined in brain homogenate and in plasma using western blot performed with automated Jess system (ProteinSimple) and ELISA respectively.
Results: Ketamine prevents development of depressive-like behavior by decreasing swimming behavior and increasing preference to sucrose in stressed animals. Ketamine treatment reduced the LPS induced secretion of IFN-γ (p <0.05 for 30 mpk), IL-6 (p <0.05 for 30 mpk), TNF-α (p <0.0001 for 30 mpk) and IL-1β in plasma. Similarly, ketamine treatment reduced the LPS induced secretion of IFN-γ (p <0.001 for 10 and 30 mpk), IL-6, TNF-α (p <0.01 for 10 and 30 mpk) and IL-1β (p <0.05 for 10 mpk, p <0.0001 for 30 mpk) in brain. The plasma and brain concentrations of ketamine were analysed using LC-MS/MS and Brain/ Plasma ratio (B/P) of ketamine at 10 and 30 mpk were calculated as 0.70 and 0.82 respectively.
Conclusion: In summary, these data emphasizes that ketamine treatment modulate cytokine level, showed good brain to plasma exposure and provides its anti-stress effects in the C57BL/6 mouse strain, which may be possible reason for the anti-depression property and is relevant to human stress-induced depression.
Comparable studies
Other preclinical and animal studies on ketamine, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists Rats | 2010 | Observational study | |
| Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex Conscious rats | 1997 | Dose-response study with microdialysis and behavioral testing | |
| NMDAR inhibition-independent antidepressant actions of ketamine metabolites Mice | 2016 | Preclinical study | |
| The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate Spinal neurons in decerebrate or pentobarbitone-anaesthetized cats and rats | 1983 | Experimental study | |
| R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects Mice | 2015 | Experimental study |
Citations in the library
Cites 6
- A Single Subanesthetic Dose of Ketamine Relieves Depression-like Behaviors Induced by Neuropathic Pain in Rats Anesthesiology October 1, 2011
- To use or not to use: an update on licit and illicit ketamine use Substance Abuse and Rehabilitation March 1, 2011
- Ketamine’s antidepressant action: beyond NMDA receptor inhibition Expert Opinion on Therapeutic Targets September 20, 2016
- Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in Rodents Neurotoxicity Research June 2, 2017
- Experimenters’ sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor Nature Neuroscience August 30, 2022
and 1 more in the library